Pasithea Therapeutics Corp. (KTTA)

Stammdaten

Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.

Unternehmen & Branche

NamePasithea Therapeutics Corp.
TickerKTTA
CIK0001841330
BoerseUS
SektorHealthcare
IndustrieBiotechnology

Wertpapier & Kennzahlen

CUSIP
ISIN
TypCommon Stock
Marktkapitalisierung5,1 Mio. USD
Beta0,25
Dividendenrendite0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2025-12-3110-K-20,427,683-2.9160,240,07055,219,238
2025-09-3010-Q-3,037,420-0.4113,630,66412,206,682
2025-06-3010-Q-3,716,157-0.6617,009,14215,178,445
2025-03-3110-Q-3,563,238-1.6114,658,98212,978,783
2024-12-3110-K-13,904,584-12.6916,064,71914,782,676
2024-09-3010-Q-2,999,834-2.8718,637,43417,813,459
2024-06-3010-Q-3,866,249-3.7117,663,38416,175,260
2024-03-3110-Q-3,860,840-3.7022,408,09919,883,469
2023-12-3110-K-15,961,658-0.4226,116,85823,398,452
2023-09-3010-Q-3,612,5900.0030,657,41128,373,606
2023-06-3010-Q-3,763,230-0.0138,149,39135,590,194
2023-03-3110-Q-3,537,679-0.0142,044,89739,135,108
2022-12-3110-K486,559-13,936,452-1.7645,180,08942,498,248
2022-09-3010-Q218,608-4,586,130-0.0149,608,30446,788,816
2022-06-3010-Q13,581-2,658,394-0.0253,027,68751,321,833
2022-03-3110-Q13,658-1,574,240-0.0151,078,56549,977,378
2021-12-3110-K15,062-2,173,521-0.2153,320,58151,420,501
2021-09-3010-Q-1,526,108-0.1721,042,41616,475,120
2021-06-3010-Q-727,947-0.09470,078
2021-03-3110-Q-549,609900,672

Fondsaktivität (Vorquartalsvergleich)

Keine Fondsdaten für dieses Unternehmen vorhanden.

Insider-Transaktionen (12 Monate)

Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.

Top-Fondshalter

Keine Fondsdaten zu dieser Aktie vorhanden.

Hinweis

Erweitert ×